News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
272 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3049)
February (3199)
March (3214)
April (3461)
May (3810)
June (3552)
July (3330)
August (2848)
September (3192)
October (3888)
November (3400)
December (2467)
Day
2 (234)
3 (202)
4 (272)
5 (185)
6 (133)
9 (193)
10 (186)
11 (137)
12 (177)
13 (113)
16 (196)
17 (169)
18 (167)
19 (153)
20 (133)
23 (165)
24 (155)
25 (141)
26 (157)
27 (105)
30 (179)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
30
Drug Development
Semafore Pharmaceuticals, Inc. Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
June 4, 2008
·
3 min read
Business
National Stem Cell Holding Appoints Kenneth Steiner, MD, MBA, as Chief Operating Officer
June 4, 2008
·
4 min read
Business
Frost & Sullivan Appoints Maz Khan to Lead Its Pharmaceutical Team in Australia
June 4, 2008
·
1 min read
Drug Development
Nuvelo, Inc. Initiates Phase 1B Clinical Trial of Anticoagulant NU172 - Phase 2 trial expected to begin in late 2008 or early 2009
June 4, 2008
·
4 min read
Business
Tomoko Kotani Joins BioReliance Corporation as Representative Director, BioReliance KK Commercial Office in Tokyo
June 4, 2008
·
1 min read
Drug Development
Reduced Hepatitis C Viral Level Achieved with DNA Vaccine Delivered by Inovio Biomedical Corporation’s Electroporation Delivery System in Phase I/II Clinical Study
June 4, 2008
·
1 min read
BioForest
ZymoGenetics, Inc. to Webcast Presentation at Needham Conference
June 4, 2008
·
1 min read
Drug Development
Celator Pharmaceuticals, Inc. Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer; Results Presented at American Society of Clinical Oncology Meeting Indicate CPX-1 Improved Clinical Outcomes Compared to Historical Data
June 4, 2008
·
3 min read
Pharm Country
NanoViricides, Inc. to Present at The NSTI Nanotech 2008 Conference in Boston
June 4, 2008
·
1 min read
Genetown
Avant Immunotherapeutics CEO to Present at the Needham & Company Biotechnology & Medical Technology Conference
June 4, 2008
·
1 min read
Previous
4 of 28
Next
